摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one | 140176-85-8

中文名称
——
中文别名
——
英文名称
(R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one
英文别名
(R)-(-)-2-phenyl-5-[(dimethylamino)methyl]isoxazolidin-3-one;(5R)-5-[(dimethylamino)methyl]-2-phenyl-1,2-oxazolidin-3-one
(R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one化学式
CAS
140176-85-8;140385-01-9
化学式
C12H16N2O2
mdl
——
分子量
220.271
InChiKey
GNTFBSFSJNWSRT-LLVKDONJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    298.2±32.0 °C(Predicted)
  • 密度:
    1.142±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.29
  • 重原子数:
    16.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    32.78
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one碘甲烷乙醚丙酮 为溶剂, 以100%的产率得到(R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one methiodide
    参考文献:
    名称:
    Nitrile oxides in medicinal chemistry. 4. Chemoenzymic synthesis of chiral heterocyclic derivatives
    摘要:
    The two enantiomers of 3-bromo-5-(hydroxymethyl)-DELTA-2-isoxazoline (1) and 2-phenyl-5-(hydroxymethyl)-isoxazolidin-3-one (9) have been prepared in enantiomeric excess higher than 90% by hydrolysis of the corresponding butyrates under the catalysis of lipase PS, which was the most selective catalyst of the enzymes tested. The pairs of enantiomers of 1 and 9 were transformed into the chiral forms of the potent muscarinic ligands 3 and 5. The results obtained with the homogeneous set of esters 6, 7, 10a-d evidence a strong dependence of reaction rate and enantioselectivity of the lipase PS-catalyzed transformations upon both the size of the acyl moiety and the shape of the group carrying the alcoholic part of the ester. In the series of esters 10a-d, the best results were obtained with butyrate 10b. Quite interestingly, on passing from the butyrate of 1 to that of 9, the value of the enantiomeric ratio remained remarkably high but the enantiopreference switched from R to S. In between lies the butyrate of 2-methyl-5-(hydroxymethyl)isoxazolidin-3-one [(+/-)-6] which was barely recognized by lipase PS and yielded alcohol (R)-(-)-2 in a modest enantiomeric excess.
    DOI:
    10.1021/jo00036a013
  • 作为产物:
    描述:
    3-(benzyloxycarbonyl)-3-chloro-N-phenylpropiono-N-hydroxamic acid 在 porcine pancreatic lipase 、 Lipase PS 吡啶 、 sodium tetrahydroborate 、 potassium phosphate buffer 、 碳酸氢钠lithium chloride 作用下, 以 四氢呋喃甲醇乙醚二氯甲烷丙酮 为溶剂, 反应 5.17h, 生成 (R)-(-)-2-phenyl-5-<(dimethylamino)methyl>isoxazolidin-3-one
    参考文献:
    名称:
    Nitrile oxides in medicinal chemistry. 4. Chemoenzymic synthesis of chiral heterocyclic derivatives
    摘要:
    The two enantiomers of 3-bromo-5-(hydroxymethyl)-DELTA-2-isoxazoline (1) and 2-phenyl-5-(hydroxymethyl)-isoxazolidin-3-one (9) have been prepared in enantiomeric excess higher than 90% by hydrolysis of the corresponding butyrates under the catalysis of lipase PS, which was the most selective catalyst of the enzymes tested. The pairs of enantiomers of 1 and 9 were transformed into the chiral forms of the potent muscarinic ligands 3 and 5. The results obtained with the homogeneous set of esters 6, 7, 10a-d evidence a strong dependence of reaction rate and enantioselectivity of the lipase PS-catalyzed transformations upon both the size of the acyl moiety and the shape of the group carrying the alcoholic part of the ester. In the series of esters 10a-d, the best results were obtained with butyrate 10b. Quite interestingly, on passing from the butyrate of 1 to that of 9, the value of the enantiomeric ratio remained remarkably high but the enantiopreference switched from R to S. In between lies the butyrate of 2-methyl-5-(hydroxymethyl)isoxazolidin-3-one [(+/-)-6] which was barely recognized by lipase PS and yielded alcohol (R)-(-)-2 in a modest enantiomeric excess.
    DOI:
    10.1021/jo00036a013
点击查看最新优质反应信息